9 Mar 2022 14:30
SourceBio International plc
("SourceBio", the "Company" or the "Group")
Medical supply support for the people of Ukraine
SourceBio International plc (AIM: SBI), a leading international provider of integrated state-of-the-art laboratory services and products, announces that following the recent events in Ukraine, the Board wishes to extend some practical support to Ukraine.
The Group is assembling an express shipment of laboratory and medical consumables, laboratory equipment and ancillary supplies to be sent to assist, as urgently as possible, the people of Ukraine. Separately, the Group is committing £100,000 of cash funding to secure the delivery of trauma kits to Ukraine.
Christopher Mills, Director and Shareholder (Harwood Capital Management Group), commented: "The rest of the world has watched with horror the unfolding events in Ukraine following Russia's invasion. Russia has created an appalling situation that cannot be ignored and we all must stand up and support the people of Ukraine. It is the morally right thing to do. Myself and the rest of the SourceBio Board feel very deeply that we must offer some direct support. I would encourage all companies, public or private, whatever their size, to provide similar tangible support to Ukraine."
Contacts:
SourceBio International plc | www.sourcebiointernational.com | |
Jay LeCoque, Executive Chairman | Via Walbrook PR | |
Tony Ratcliffe, Chief Financial Officer |
| |
|
| |
Walbrook PR Limited | Tel: 020 7933 8780 or sourcebio@walbrookpr.com | |
Paul McManus / Sam Allen | Mob: 07980 541 893 / 07502 558 258 | |
About SourceBio International plc www.sourcebiointernational.com
SourceBio is a leading international provider of integrated state-of-the-art laboratory services and products with clients in the healthcare, clinical, life science research and biopharma industries, with a focus on improving patient diagnosis, management and care. Group revenues are derived from four business units:
· Healthcare Diagnostics - histopathology cancer screening and clinical diagnostic services for the NHS and private healthcare across the UK and Ireland.
· Genomics - DNA sequencing services and Precision Medicine offering for pharmaceutical and biotechnology companies, academia, contract research organisations (CROs) and other research groups in the UK, Europe and North America.
· Stability Storage - shelf-life testing services and equipment for pharmaceutical and biotechnology companies, contract manufacturers and analytical testing companies from around the world but primarily in the UK, Ireland and the USA
· Infectious Disease Testing - a range of COVID-19 testing services for commercial enterprises, private healthcare groups and the NHS. Utilising multiple technologies, SourceBio offers screening, gold standard RT-PCR and whole genome sequencing COVID-19 testing solutions and operates under ISO 15189 accreditation. SourceBio also provides employee testing solutions to industry, direct to consumer home test kits and venue testing.
More details on Group operations can be found here: www.sourcebioscience.com
SourceBio International plc (SBI) is listed on the AIM market of the London Stock Exchange.